Loading chat...
OK HB2607
Bill
Status
2/1/2016
Primary Sponsor
Jeannie McDaniel
Click for details
AI Summary
-
Requires the Oklahoma State Board of Health to expand the existing newborn screening program to include testing for adrenoleukodystrophy (ALD), a genetic disorder
-
Expansion of screening is contingent on funds becoming available to the State Board of Health
-
Amends Section 1-533 of Title 63 (Oklahoma Statutes 2011), which governs education and newborn screening programs for metabolic and genetic disorders
-
State Board of Health is authorized to promulgate rules necessary to implement the screening requirement
-
Effective date set for November 1, 2018
Legislative Description
Public health and safety; requiring State Board of Health to expand education and newborn screening program to include adrenoleukodystrophy; effective date.
Last Action
Referred to Appropriations and Budget Health Subcommittee
2/2/2016